Cargando…

Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery

Invasive Pulmonary Aspergillosis (IPA) and Pneumocystis jiroveci Pneumonia (PCP) are serious fungal pulmonary diseases for immunocompromised patients. The brand name drug CANCIDAS(®) (Caspofungin acetate for injection) is FDA approved to treat IPA, but is only 40% effective. Efficacious drug levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Iching G., Ryckman, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067632/ https://www.ncbi.nlm.nih.gov/pubmed/33916988 http://dx.doi.org/10.3390/pharmaceutics13040504

Ejemplares similares

Aerosolized Delivery of Antifungal Agents
por: Le, Jennifer, et al.
Publicado: (2010)

Analysis of the Localization of Schizosaccharomyces pombe Glucan Synthases in the Presence of the Antifungal Agent Caspofungin
por: San-Quirico, Esther, et al.
Publicado: (2023)

In Vitro Assessment of Antifungal Caspofungin on Leishmania donovani Culture Isolation
por: Bhattarai, Narayan Raj, et al.
Publicado: (2017)

Phosphoproteomics of Aspergillus fumigatus Exposed to the Antifungal Drug Caspofungin
por: Mattos, Eliciane Cevolani, et al.
Publicado: (2020)

Mangiferin enhances the antifungal activities of caspofungin by destroying polyamine accumulation
por: Shen, Juan, et al.
Publicado: (2021)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
por: Victorio, Gerardo Becerra, et al.
Publicado: (2017)

Warfarin treatment and antifungal agent caspofungin for severe fungal infection in a patient previously treated with radiotherapy for oropharyngeal cancer
por: Vedtofte, Thomas, et al.
Publicado: (2015)

Antifungal Susceptibility of Oral Candida Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
por: Alkhars, Naemah, et al.
Publicado: (2023)

The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase
por: Siala, Wafi, et al.
Publicado: (2016)

A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi
por: dos Reis, Thaila Fernanda, et al.
Publicado: (2023)

Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans
por: Chen, Ying-Lien, et al.
Publicado: (2013)

1412. Caspofungin and Anidulafungin Behave as Fungistatic Agents Against Candida auris
por: Dudiuk, Catiana, et al.
Publicado: (2018)

Elevated Vacuolar Uptake of Fluorescently Labeled Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic Yeast
por: Jaber, Qais Z., et al.
Publicado: (2020)

Pulmonary aerosol delivery and the importance of growth dynamics
por: Haddrell, Allen E, et al.
Publicado: (2017)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Döring, Michaela, et al.
Publicado: (2012)

Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents
por: Calvo, Natalia L., et al.
Publicado: (2019)

Efficacy of the Combination of Voriconazole and Caspofungin in Experimental Pulmonary Aspergillosis by Different Aspergillus Species
por: Zhang, Ming, et al.
Publicado: (2013)

Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery
por: Chiang, Po-Chang, et al.
Publicado: (2009)

Bacillus subtilis engineered for topical delivery of an antifungal agent
por: Montgomery, Veronica A., et al.
Publicado: (2023)

Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension
por: Mansour, Heidi M.
Publicado: (2018)

Unraveling Caspofungin Resistance in Cryptococcus neoformans
por: Papon, Nicolas, et al.
Publicado: (2021)

Nonstationary Pharmacokinetics of Caspofungin in ICU Patients
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2020)

Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies
por: Osman, Nashwa, et al.
Publicado: (2018)

Preliminary investigation tests of novel antifungal topical aerosol
por: Kapadia, Monali M., et al.
Publicado: (2012)

Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats
por: Leshinsky, Jana, et al.
Publicado: (2017)

An update on the development of novel antifungal agents for eumycetoma
por: Chandler, David J., et al.
Publicado: (2023)

Puupehenone, a Marine-Sponge-Derived Sesquiterpene Quinone, Potentiates the Antifungal Drug Caspofungin by Disrupting Hsp90 Activity and the Cell Wall Integrity Pathway
por: Tripathi, Siddharth K., et al.
Publicado: (2020)

Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
por: Park, Dae Won, et al.
Publicado: (2006)

Combination of amphotericin B and caspofungin in the treatment of mucormycosis
por: Gargouri, Marwa, et al.
Publicado: (2019)

Efficacy and safety of caspofungin for patients with hepatic insufficiency
por: Ran, Xiaoyun, et al.
Publicado: (2022)

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia
por: Sattarzadeh Badkoubeh, Roya, et al.
Publicado: (2022)

Aerosol Delivery of Surfactant Liposomes for Management of Pulmonary Fibrosis: An Approach Supporting Pulmonary Mechanics
por: Kotta, Sabna, et al.
Publicado: (2021)

A narrative review on trans-nasal pulmonary aerosol delivery
por: Li, Jie, et al.
Publicado: (2020)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Successful management of recalcitrant fungal keratitis with topical caspofungin
por: Goel, Siddhi, et al.
Publicado: (2022)

Transcriptional and translational landscape of Candida auris in response to caspofungin
por: Zamith-Miranda, Daniel, et al.
Publicado: (2021)

Are Systemic Voriconazole and Caspofungin Ototoxic? An Experimental Study with Rats
por: Aydın, Emine, et al.
Publicado: (2012)

Case Report: Successful Management of Refractory Keratomycosis in an Alpaca Using Penetrating Keratoplasty and Combination Antifungal Therapy (Caspofungin 0.5% and Terbinafine 1%)
por: Foote, Braidee C., et al.
Publicado: (2021)

Treatment of invasive candidiasis with caspofungin in the intensive care unit
por: DiNubile, MJ, et al.
Publicado: (2003)

Application of caspofungin in China compared with amphotericin B and fluconazole
por: Zhang, Chunyu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6btip6198lb39r39hal5qlv9cs